The estimated Net Worth of William Lewis is at least $49.1 Milion dollars as of 13 May 2024. Mr. Lewis owns over 22,198 units of Insmed Inc stock worth over $27,948,935 and over the last 12 years he sold INSM stock worth over $13,952,447. In addition, he makes $7,175,090 as Chairman of the Board, President oraz Chief Executive Officer at Insmed Inc.
William has made over 29 trades of the Insmed Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 22,198 units of INSM stock worth $566,493 on 13 May 2024.
The largest trade he's ever made was selling 400,000 units of Insmed Inc stock on 25 June 2019 worth over $10,400,000. On average, William trades about 37,725 units every 77 days since 2012. As of 13 May 2024 he still owns at least 384,125 units of Insmed Inc stock.
You can see the complete history of Mr. Lewis stock trades at the bottom of the page.
William H. Lewis is a Chairman of the Board, President, Chief Executive Officer of Insmed Inc. Mr. Lewis has nearly 15 years of executive experience in the life sciences industry and a track record of success for over 20 years in the pharmaceutical and finance industries both in the United States and internationally. During his tenure at Aegerion, Mr. Lewis played a pivotal role in re-orienting the company's strategy to focus on rare disease indications, enabling Aegerion to conduct a successful initial public offering in 2010. The Board believes that Mr. Lewis brings significant qualifications to his role as Chairman due to his experience as our CEO since 2012 and his experience as an executive at Aegerion. His professional experience offers the Board significant insights and experience with financing, orphan drug development and commercialization, and international business development.
As the Chairman of the Board, President oraz Chief Executive Officer of Insmed Inc, the total compensation of William Lewis at Insmed Inc is $7,175,090. There are no executives at Insmed Inc getting paid more.
William Lewis is 51, he's been the Chairman of the Board, President oraz Chief Executive Officer of Insmed Inc since 2018. There are 17 older and 4 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
William's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis oraz Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: